Search results for "Xanthomatosis"

showing 10 items of 13 documents

Two-year-old girl with tuberous xanthomas.

2018

A 2-year-old girl was referred for evaluation because she had two nodular lesions located on both heels, and another elongated lesion in the intergluteal cleft. On physical examination, two yellow to orange well-defined nodules, suggestive of xanthomas, were bilaterally located on the Achilles tendon areas (figure 1A). Moreover, another yellowish, slightly raised lesion with band-like morphology was seen in the intergluteal cleft (figure 1B). There were no other anomalies on physical examination. Figure 1 (A) Tuberous xanthoma located on the left heel. (B) Planar xanthoma located in the intergluteal cleft. (C) Peripheral blood smear examination showing numerous red cells and two macrothromb…

0301 basic medicinePathologymedicine.medical_specialtyIntergluteal cleftHypercholesterolemiaPhysical examination030204 cardiovascular system & hematologyXanthomaHigh cholesterolLipid Metabolism Inborn ErrorsPathology and Forensic MedicineLesion03 medical and health sciences0302 clinical medicineBiopsymedicineXanthomatosisHumansAchilles tendonmedicine.diagnostic_testbusiness.industryATP Binding Cassette Transporter Subfamily G Member 8PhytosterolsGeneral Medicinemedicine.diseaseIntestinal Diseases030104 developmental biologymedicine.anatomical_structureChild PreschoolMutationFemalemedicine.symptomLipid profilebusinessJournal of clinical pathology
researchProduct

Homozygous familial hypercholesterolemia with severe involvement of the aortic valve—A sibling‐controlled case study on the efficacy of lipoprotein a…

2020

Background Homozygous familial hypercholesterolemia (hoFH) can cause severe atherosclerotic cardiovascular disease (ASCVD) in early infancy. Diagnosis and initiation of effective lipid-lowering therapy (LLT) are recommended as early as possible to prevent ASCVD-related morbidity and mortality. Methods The clinical courses of a pair of siblings with an identical hoFH genotype, who exhibited major similarities of their clinical phenotype were analyzed in a case-control fashion including the family. Results The older sibling was diagnosed with hoFH at the age of 4. Untreated LDL-cholesterol (LDL-C) was 17 mmol/L (660 mg/dL). LLT including lipoprotein apheresis (LA) was initiated and has been s…

AdultMaleAortic valvemedicine.medical_specialtyGenotypeBiopsyLipoproteinsFamilial hypercholesterolemia030204 cardiovascular system & hematologyHyperlipoproteinemia Type II03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEzetimibeInternal medicineXanthomatosisHumansMedicineSiblingChildAortaRetrospective StudiesFamily Healthbusiness.industryCholesterolSiblingsPCSK9HomozygoteMechanical Aortic ValveCholesterol LDLHematologyGeneral Medicinemedicine.diseaseLipidsPhenotypemedicine.anatomical_structurechemistryEchocardiographyAortic ValveCase-Control StudiesChild PreschoolAortic valve stenosisBlood Component RemovalFemalelipids (amino acids peptides and proteins)Proprotein Convertase 9business030215 immunologymedicine.drugJournal of Clinical Apheresis
researchProduct

Real-time spatial compound sonography of Achilles tendon in patients with heterozygous familial hypercholesterolaemia and normal physical examination

2007

This study was undertaken to assess the prevalence and ultrasound features of Achilles tendon xanthomas (ATX) in patients with heterozygous familial hypercholesterolemia (HFH) and normal physical examination studied with high-resolution ultrasonography (HRUS) and, secondarily, to evaluate the role of real-time spatial compound sonography (CS) in terms of image quality.Both Achilles tendons of 40 patients with HFH were studied with HRUS and CS. Two experienced radiologists evaluated by consensus the presence of ATX described as (1) tendon thickening and/or (2) focal hypoechoic areas and the quality of images obtained with the two techniques.Ten out of 80 tendons showed thickening (mean: 11.2…

AdultMaleHeterozygotemedicine.medical_specialtyAdolescentPhysical examinationFamilial hypercholesterolemiaAchilles TendonHyperlipoproteinemia Type IIMuscular DiseasesXanthomatosismedicineHumansRadiology Nuclear Medicine and imagingIn patientChildPhysical ExaminationAgedUltrasonographyNeuroradiologyAchilles tendonmedicine.diagnostic_testbusiness.industryUltrasoundInterventional radiologyGeneral MedicineMiddle Agedmedicine.diseaseSurgerySonographymedicine.anatomical_structureFemaleUltrasonographybusinessLa radiologia medica
researchProduct

Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients

2017

Familial hypercholesterolemia (FH) is characterized by high low-density lipoprotein (LDL) cholesterol with co-dominant transmission and high risk of cardiovascular disease (CVD), although with high variability among subjects. Currently, CVD stratification tools for heterozygous FH (HeFH) are not available. A definition of severe HeFH has been recently proposed by the International Atherosclerosis Society (IAS), but it has not been validated. Our study aims to see clinical characteristics and prevalence of CVD in subjects defined as severe HeFH by IAS criteria. Probable or definite HeFH introduced in the Dyslipidemia Registry of Spanish Arteriosclerosis Society were analyzed by the IAS crite…

AdultMaleHeterozygotemedicine.medical_specialtyMultivariate analysisFamilial hypercholesterolemia030204 cardiovascular system & hematologyRisk AssessmentSeverity of Illness IndexHyperlipoproteinemia Type IITendons03 medical and health sciences0302 clinical medicineMuscular DiseasesInternal medicineSeverity of illnessPrevalenceXanthomatosismedicineHumans030212 general & internal medicineUnivariate analysisbusiness.industryCholesterol LDLOdds ratioArteriosclerosisMiddle Agedmedicine.diseaseLogistic ModelsEndocrinologyCardiovascular DiseasesMultivariate AnalysisCardiologyFemaleCardiology and Cardiovascular MedicinebusinessRisk assessmentDyslipidemiaThe American Journal of Cardiology
researchProduct

Oral verruciform xanthoma : report of 13 new cases and review of the literature

2018

Background Oral verruciform xanthoma (OVX) is a rare lesion. The purpose of the present study is to describe the clinical features of 13 OVXs and review all cases reported in the English literature. Material and Methods Thirteen cases of OVX diagnosed during a 47-year period were retrospectively collected. The patients’ gender and age, as well as the main clinical features of the lesions were retrieved from the biopsy request forms. Pubmed®, Scopus® and Google ScholarTM electronic databases were searched with the key word “verruciform xanthoma”. Only cases of histologically confirmed OVX were included in the study. Results The 13 OVXs represented approximately 0.04% of 35,617 biopsies acces…

AdultMalemedicine.medical_specialtyReviewAsymptomatic030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinePathognomonicTongueBiopsyXanthomatosisHumansMedicineGeneral DentistryAgedRetrospective StudiesVerruciform xanthomaOral Medicine and Pathologymedicine.diagnostic_testbusiness.industryNodule (medicine)030206 dentistryMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Dermatology3. Good healthmedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASFemaleSurgeryHard palatemedicine.symptomDifferential diagnosisMouth Diseasesbusiness
researchProduct

Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy.

2013

Abstract Objective To determine the spectrum of gene mutations and the genotype–phenotype correlations in patients with Autosomal Dominant Hypercholesterolemia (ADH) identified in Italy. Methods The resequencing of LDLR , PCSK9 genes and a selected region of APOB gene were conducted in 1018 index subjects clinically heterozygous ADH and in 52 patients clinically homozygous ADH. The analysis was also extended to 1008 family members of mutation positive subjects. Results Mutations were detected in 832 individuals: 97.4% with LDLR mutations, 2.2% with APOB mutations and 0.36% with PCSK9 mutations. Among the patients with homozygous ADH, 51 were carriers of LDLR mutations and one was an LDLR / …

Adultmedicine.medical_specialtyHeterozygoteSettore MED/09 - Medicina InternaApolipoprotein BCoronary DiseaseBiologyGene mutationmedicine.disease_causeHyperlipoproteinemia Type IITendonschemistry.chemical_compoundReference ValuesInternal medicinemedicineXanthomatosisHumansGeneAllelesGenetic Association StudiesAgedGeneticsMutationCholesterolPCSK9Cholesterol HDLSerine EndopeptidasesSmokingAlcohol Dehydrogenasenutritional and metabolic diseasesCholesterol LDLMiddle AgedEndocrinologyPhenotypechemistryItalyLDL receptorMutationbiology.proteinAutosomal dominanthypercholesterolemia LDL receptor Apolipoprotein B PCSK9 Mutationslipids (amino acids peptides and proteins)Allelic heterogeneityFemaleProprotein ConvertasesProprotein Convertase 9Cardiology and Cardiovascular MedicineAtherosclerosis
researchProduct

Laser treatment of giant xanthelasma palpebrarum

2013

Xanthelasma palpebrarum is the most common cutaneous xanthoma. It typically presents in middle-aged and older adults, most often around the eyelids. The diagnosis is made clinically. Giant xanthelasmas palpebrarum are xanthelasmas that extensively affect the superior and inferior bilateral eyelids. Many techniques have been put forward for treating these lesions (surgical, laser, and chemical techniques), but we describe our experience in the treatment of giant xanthelasmas by ultrapulsed CO2 laser. Between 2009 and 2012, in the Division of Plastic and Reconstructive Surgery at the University of Palermo, 12 patients with giant xanthelasmas were treated using a CO2 laser. The laser parameter…

Adultmedicine.medical_specialtyReconstructive surgeryBig xanthelasmaSettore MED/19 - Chirurgia PlasticaHealing timeDermatologylaw.inventionlawEyelid surgeryXanthomatosismedicineHumansAgedWound HealingCo2 laserbusiness.industryLaser treatmentUltrapulsed CO2 laserCutaneous xanthomaBenign lesion of eyelidMiddle Agedmedicine.diseaseLaserSurgeryConservative treatmentTreatment OutcomeXanthelasmaEyelid DiseasesLasers GasSurgerybusinessConservative treatmentLasers in Medical Science
researchProduct

Oral verruciform xanthoma and erythroplakia associated with chronic graft-versus-host disease: A rare case report and review of the literature

2017

Abstract Background Oral verruciform xanthoma is an uncommon benign lesion. Although oral verruciform xanthoma occurs in healthy individuals, it has been also reported in association with some inflammatory conditions. The aim of this study is to report a case of oral verruciform xanthoma associated with chronic graft-versus-host disease and to review the literature on this topic. Case presentation A 47-year-old Caucasian male presented to the Sector of Oral Medicine “V. Margiotta”, University Policlinic “P. Giaccone” of Palermo complaining of a mass on the gingiva. He first noticed the painless mass 1 year ago. He reported to have undergone allogenic hematopoietic stem cell transplantation …

Genetics and Molecular Biology (all)MaleVerruciform xanthomaBiopsylcsh:MedicineGraft vs Host DiseaseCase ReportBiochemistryChronic graft versus-host-disease; Erythroplakia; Oral potential malignant disorder; Verruciform xanthoma; Biochemistry Genetics and Molecular Biology (all)030207 dermatology & venereal diseases0302 clinical medicinelcsh:QH301-705.5Verruciform xanthomaErythroplakiamedicine.diagnostic_testChronic graft versus-host-diseaseHematopoietic Stem Cell TransplantationMED/28 - MALATTIE ODONTOSTOMATOLOGICHEGeneral MedicineMiddle AgedPrecursor Cell Lymphoblastic Leukemia-Lymphomamedicine.anatomical_structure030220 oncology & carcinogenesisOral erythroplakiamedicine.symptommedicine.medical_specialtyGeneral Biochemistry Genetics and Molecular BiologyOral potential malignant disorder03 medical and health sciencesTongueBiopsymedicineXanthomatosisLS7_3Humanslcsh:Science (General)Biochemistry Genetics and Molecular Biology (all)business.industrylcsh:RAmbientaleNodule (medicine)medicine.diseaseDermatologystomatognathic diseaseslcsh:Biology (General)ErythroplasiaChronic DiseaseHard palatebusinessMouth DiseasesOral medicineErythroplakialcsh:Q1-390
researchProduct

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper fr…

2014

Item does not contain fulltext AIMS: Homozygous familial hypercholesterolaemia (HoFH) is a rare life-threatening condition characterized by markedly elevated circulating levels of low-density lipoprotein cholesterol (LDL-C) and accelerated, premature atherosclerotic cardiovascular disease (ACVD). Given recent insights into the heterogeneity of genetic defects and clinical phenotype of HoFH, and the availability of new therapeutic options, this Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society (EAS) critically reviewed available data with the aim of providing clinical guidance for the recognition and management of HoFH. METHODS AND RESULTS: Early diagn…

Homozygous Familial HypercholesterolemiaSettore MED/09 - Medicina InternaVascular damage Radboud Institute for Health Sciences [Radboudumc 16]MipomersenLipoprotein apheresisGene FrequencyDiagnosisconsensuMedicineChildPhenotypic heterogeneityCiències de la salutAnticholesteremic AgentsHomozygoteCiencias de la saludPedigree3. Good healthEuropePhenotypeCardiovascular DiseasesPractice Guidelines as TopicBlood Component Removallipids (amino acids peptides and proteins)HipercolesterolèmiaHIPERCOLESTEROLEMIA (DIAGNÓSTICO)Cardiology and Cardiovascular MedicineLipoprotein apheresismedicine.medical_specialtyConsensusClinical UpdateEvinacumabReviewsguide line1102 Cardiovascular Medicine And Haematology1016-5169Diagnosis DifferentialHyperlipoproteinemia Type IIGenetic HeterogeneityArcus SenilisHomozygous familial hypercholesterolaemiaGeneticsXanthomatosisHumansGynecologybusiness.industryStatinsHealth sciencesCholesterol LDLAtherosclerosisEzetimibeLomitapideLiver TransplantationEarly DiagnosisCardiovascular System & HematologyHomozygous familial hypercholesterolaemia; consensus; guide lineMutationEuropean atherosclerosis societybusinessAterosclerosiEuropean Heart Journal
researchProduct

h-caldesmon immunoreactivity in atypical fibroxanthoma: implications for the differential diagnosis.

2017

MalePathologymedicine.medical_specialtySkin NeoplasmsSkin DiseasesH caldesmonPathology and Forensic MedicineDiagnosis Differential030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicineXanthomatosisHumansAgedAged 80 and overHistiocytoma Benign Fibrousbusiness.industryAtypical fibroxanthomamedicine.diseaseImmunohistochemistry030220 oncology & carcinogenesisImmunohistochemistryCalmodulin-Binding ProteinsFemaleDifferential diagnosisbusinessPathology
researchProduct